| Identifiers | |
|---|---|
| |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C21H32O3 |
| Molar mass | 332.484 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
10-Hydroxyhexahydrocannabinol (10-OH-HHC) is a semi-synthetic cannabinoid which has been sold as a designer drug, first identified in Germany in December 2024.12
See also
See also
- 8-Hydroxyhexahydrocannabinol (8-OH-HHC)
- 9-Hydroxyhexahydrocannabinol (9-OH-HHC)
- 11-Hydroxyhexahydrocannabinol (11-OH-HHC)
- 10-Hydroxy-THC
- 10-Hydroxy-HHCP
- Hexahydrocannabinol (HHC)
References
References
- "European Drug Report 2025 – Full Book" (PDF). European Union Drugs Agency (euda.europa.eu). 6 June 2025.
- Golombek P, Müller M, Barthlott I, Sproll C, Lachenmeier DW (June 2020). "Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature". Toxics. 8 (2): 41. Bibcode:2020Toxic...8...41G. doi:10.3390/toxics8020041. PMC 7357058. PMID 32503116.